Mylan Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS, and what generic and branded alternatives to MYLAN LABS drugs are available?
MYLAN LABS has one hundred and forty-eight approved drugs.
There are eleven tentative approvals on MYLAN LABS drugs.
Drugs and US Patents for Mylan Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 205160-001 | Oct 31, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | DESOGESTREL AND ETHINYL ESTRADIOL | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 202296-001 | Aug 30, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Labs Ltd | CAPREOMYCIN SULFATE | capreomycin sulfate | INJECTABLE;INJECTION | 202634-001 | Nov 27, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mylan Labs Ltd | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 206091-002 | Oct 26, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.